Aspire Biopharma Holdings, Inc., to Launch the Next Generation of Pre-Workout Performance Supplement

March 3, 2025 7:30 AM

Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-protected disruptive drug delivery mechanism technology, announced today plans to launch a single dose pre-workout supplement utilizing Aspire's patent-pending and proprietary sublingual delivery technology in 2025. Pre-workout supplements are multi-ingredient dietary formulas designed to increase energy and provide nutrients that can...

Read more

Advanced Bionics Debuts AB ListenFit APP as Part of Advanced Digicare Portfolio

March 3, 2025 7:01 AM

Advanced Bionics (AB), a global leader in cochlear implant technology, is proud to announce the launch of AB ListenFit*, a new mobile app that provides quick and simple tests to let users track their hearing progress. This new resource adds to the collection of free, smart, digital connections from AB. The Advanced DigiCare portfolio includes apps, online resources, and community portals for cochlear implant (CI) candidates, users, or those with...

Read more

Cercare Medical Secures €7.4 Million in New Funding Round to Accelerate Growth in Key Markets

March 3, 2025 7:00 AM

Cercare Medical, a leader in perfusion software for stroke and neurodegenerative diseases since 2013, announced today that it has raised €7.4 million (£6.17million GBP / $7.77 million USD) in its latest funding round, led by UK-based West Hill Capital. This funding will be used to expand operations in key markets, with a focus on the United States, the UK, and selected European countries.Cercare Medical's cutting-edge software (CMN) provides...

Read more

AbbVie and Gubra Announce License Agreement to Develop an Amylin Analog for the Treatment of Obesity

March 3, 2025 1:45 AM

HØRSHOLM, DK / ACCESS Newswire / March 03, 2025 / Gubra (CPH:GUBRA)Partnership marks AbbVie's entrance into the obesity fieldAgreement will enable the incorporation of GUB014295, an amylin peptide discovered and developed by Gubra, into AbbVie's global infrastructure for developing and commercializing therapies for patients in needAbbVie (NYSE : ABBV) and Gubra A/S (CPSE:GUBRA), a company specializing in preclinical contract research services...

Read more

Onco-Innovations CEO Thomas O’Shaughnessy Featured on Conversations That Matter to Discuss Breakthroughs in Cancer Treatment, AI Integration, and Potential Global Expansion

March 2, 2025 3:00 PM

Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt: W1H)(WKN:A3EKSZ) ("Onco" or the "Company") is pleased to announce that its CEO, Thomas O'Shaughnessy, was recently featured in an exclusive interview on Conversations That Matter, a widely distributed long-form program showcasing thought leaders shaping the world. The program is featured in the Vancouver Sun and is broadcast across multiple television networks in British Columbia,...

Read more

Virtual Care Platforms Experience Unprecedented Growth, Ushering in the Next Era of Hybrid Healthcare, Reports Black Book Research

March 2, 2025 12:00 PM

A new independent survey by Black Book Research reveals a surge in virtual care platform adoption, with 775 healthcare organizations reporting active use of AI-driven remote patient monitoring (RPM), virtual hospitals, virtual nursing, and telehealth solutions to optimize care delivery. As hospitals and health systems advance toward hybrid care models, seamless integration of virtual care technologies is becoming a defining factor in improving...

Read more

Beyond the Clinic: Physiowell’s Guide to Continued Wellness at Home

March 2, 2025 7:15 AM

Recovery doesn't stop when you leave the clinic. In fact, maintaining your progress at home is just as important as the sessions you attend with your physiotherapist. By incorporating home physiotherapy exercises into your daily routine, you can enhance mobility, prevent setbacks, and speed up healing. Whether you're recovering from surgery, managing chronic pain, or improving flexibility, Physiowell provides expert guidance to help you continue...

Read more

CORRECTION FROM SOURCE: AI to Transform Independent and Assisted Living With Addison Virtual Caregiver

March 1, 2025 3:00 PM

As the market demands excellence in resident care, Addison Care is revolutionizing independent and assisted living with its AI-powered virtual care solution. Offering unmatched support, safety, retention, and profitability, Addison Care empowers senior living communities to improve resident outcomes while reducing operational risks at just $8 per day.Woman using an AddisonWoman sitting on her couch using an Addison In a landscape where nearly...

Read more

Alpha Genesis, Inc. Calls for Accountability as PETA's Euthanasia Toll Surpasses 50,000 Dogs and Cats

March 1, 2025 10:00 AM

Publicly accessible records reveal that People for the Ethical Treatment of Animals (PETA) has euthanized more than 50,000 dogs and cats at its Virginia-based facility since reporting began. These findings have sparked renewed calls for transparency, ethical alternatives, and reform within the organization that claims to advocate for animal welfare.According to data obtained from public records, PETA has consistently euthanized a staggering...

Read more

Electronic Caregiver and Samsung Highlight Addison Care: AI-Powered Virtual Home Care and Remote Patient Monitoring at HIMSS 2025

March 1, 2025 9:00 AM

Revolutionizing Care for Older Adults, Patients, and Family Caregivers with 24/7 Engagement and Support. Electronic Caregiver and Samsung Electronics America are proud to showcase cutting-edge Virtual Care at HIMSS 2025, introducing Addison Care-a 3D Virtual Caregiver designed to deliver round-the-clock engagement and support in the home. Addressing the global challenge of chronic conditions, aging populations, and caregiving demands, Addison...

Read more

BioNxt Solutions Announces Closing of First Tranche of Convertible Debenture Unit Private Placement

February 28, 2025 7:35 PM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:4XT), is pleased to announce today that it has closed the first tranche of its previously announced non‐brokered private placement (the "Offering") of convertible debenture units ("Debenture Units") for gross proceeds of $1,600,000. Each Debenture Unit consists of: (i) $0.50 principal amount of 8.0% unsecured convertible debentures (the "Debentures") and (ii) one...

Read more

Forensic Psychiatry at the Frontiers: The Ever-Evolving Challenges of Michael Welner

February 28, 2025 7:25 PM

Step into some of the most impactful and closely studied cases in forensic psychiatry and forensic science in America over recent decades, and you're likely to find the influential work of Dr. Michael Welner, Chairman of The Forensic Panel. A Professor of Psychiatry at Mt. Sinai School of Medicine, Dr. Welner has most recently been at the heart of court proceedings of highly contested confessions of prisoners at Guantanamo Bay, including the...

Read more

Avant Brands Reports Record Fiscal 2024 Results

February 28, 2025 4:30 PM

Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BUP)("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products, today released its financial results for fiscal year ended November 30, 2024 ("FY 2024"). The Company achieved significant financial milestones driven by strategic international expansion and operational improvements.In Q4 2024, Avant Brands reports records across key financial metrics, underscoring...

Read more

MicroGenDX Launches "Rapid H5," a PCR Test for H5 Influenza Detection

February 28, 2025 4:00 PM

MicroGenDX, a leader in clinical molecular diagnostics, is launching Rapid H5, a qPCR test designed to detect H5 avian influenza A variants, such as H5N1, the current bird flu strain.Intended for physician use in hospitals, clinics, and other healthcare facilities, the test provides rapid, accurate detection to support patient care, clinical decisions, and H5 influenza case management.Combatting the Rising H5N1 Threat with Precision TestingThe...

Read more

Day in the Life: Ansel, DaVita Home Hemodialysis Registered Nurse

February 28, 2025 1:30 PM

Ansel, Home Hemodialysis Registered Nurse at DaVita, is a DaVita Global Nurse from the Philippines and was recruited while working as an international dialysis nurse in Abu Dhabi. He wanted to be a part of DaVita's culture, benefits, professional and personal growth. When Ansel became a DaVita teammate, he experienced this and so much more.About DaVita Inc.DaVita (NYSE:DVA) is a health care provider focused on transforming care delivery to...

Read more

Moderna Receives Medicines and Healthcare Products Regulatory Agency Marketing Authorization in the UK for RSV Vaccine

February 28, 2025 10:30 AM

Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted marketing authorization for mRESVIA (mRNA-1345), indicated for active immunization for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in adults 60 years of age and older."The MHRA's authorization of our RSV vaccine is an important milestone for Moderna's...

Read more

Survey Reveals Major Gaps in Workplace Support for Women's Midlife Health Needs

February 28, 2025 9:41 AM

New survey findings released today reveal significant gaps between awareness of menopause-related workplace challenges and organizational support for affected employees. The report, "Understanding the Health Issues of Women in Midlife," examines how employers understand and address the difficulties faced by employees in midlife, including women experiencing perimenopause and menopause.HR.com's HR Research Institute conducted a survey of 308 HR...

Read more

Xtant Medical to Issue Fourth Quarter and Year End 2024 Financial Results on March 6, 2025

February 28, 2025 8:00 AM

Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the fourth quarter and year ended December 31, 2024, after the close of the financial markets on Thursday, March 6, 2025.Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will host a...

Read more

The Power of Flossing: Insights from Dr. Esha Persad, Seminole Dentist

February 27, 2025 9:00 PM

While most people acknowledge the importance of brushing their teeth daily, the habit of flossing often takes a back seat in oral hygiene routines. Seminole-based dentist Dr. Esha Persad, DDS, a leading expert in comprehensive dental care, sheds light on why flossing is an indispensable component of maintaining not only oral health but overall well-being. Known for her patient-focused approach and dedication to community health education, Dr....

Read more

Onco-Innovations' Inka Health Innovative AI-Driven Oncology Study Paves the Way for New Research

February 27, 2025 6:00 PM

Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H,WKN: A3EKSZ) ("Onco" or the "Company") is pleased to provide information regarding its wholly-owned subsidiary, Inka Health ("Inka"), which has made significant strides in advancing AI-driven oncology research by leading a transformative study protocol1 published in medRxiv in September 2024, focused on AI-generated synthetic patient models. This innovative research aims to advance...

Read more